These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9759584)

  • 1. Systemic treatment of metastatic melanoma with chemotherapy.
    Green RJ; Schuchter LM
    Hematol Oncol Clin North Am; 1998 Aug; 12(4):863-75, viii. PubMed ID: 9759584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for metastatic melanoma.
    Mandarà M; Nortilli R; Sava T; Cetto GL
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic chemotherapy in the treatment of malignant melanoma.
    Lens MB; Eisen TG
    Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tamoxifen in the treatment of malignant melanoma.
    Lens MB; Reiman T; Husain AF
    Cancer; 2003 Oct; 98(7):1355-61. PubMed ID: 14508820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA; Sarli R; Falkson G
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract]   [Full Text] [Related]  

  • 6. Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.
    O'Day SJ; Gammon G; Boasberg PD; Martin MA; Kristedja TS; Guo M; Stern S; Edwards S; Fournier P; Weisberg M; Cannon M; Fawzy NW; Johnson TD; Essner R; Foshag LJ; Morton DL
    J Clin Oncol; 1999 Sep; 17(9):2752-61. PubMed ID: 10561350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
    O'Day SJ; Atkins MB; Boasberg P; Wang HJ; Thompson JA; Anderson CM; Gonzalez R; Lutzky J; Amatruda T; Hersh EM; Weber JS
    J Clin Oncol; 2009 Dec; 27(36):6207-12. PubMed ID: 19917850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemotherapy for melanoma: rational therapeutics in the search for weapons of melanoma destruction.
    Margolin KA
    Cancer; 2004 Aug; 101(3):435-8. PubMed ID: 15274056
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy for disseminated malignant melanoma.
    Abbott KL; Harman GS
    Anticancer Drugs; 1995 Aug; 6(4):489-97. PubMed ID: 7579552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic melanoma: chemotherapy to biochemotherapy.
    O'Day SJ; Kim CJ; Reintgen DS
    Cancer Control; 2002; 9(1):31-8. PubMed ID: 11907464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe panuveitis in a metastatic cutaneous melanoma patient treated with vemurafenib].
    Boiché M; Conart JB; Angioi-Duprez K
    J Fr Ophtalmol; 2018 Jun; 41(6):e291-e292. PubMed ID: 29908650
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma.
    Ugurel S; Kiecker F; Fröhling S; Wetter A; Bankfalvi A; Sucker A; Zimmer L; Livingstone E; Roesch A; Becker JC; Schadendorf D
    Eur J Cancer; 2017 Sep; 83():142-145. PubMed ID: 28735071
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemoimmunotherapy in metastatic melanoma--is there a need for the double?
    Schrader AJ
    Anticancer Drugs; 2000 Mar; 11(3):143-8. PubMed ID: 10831272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma.
    Harting MS; Kim KB
    Melanoma Res; 2004 Dec; 14(6):517-20. PubMed ID: 15577323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
    Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P
    J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy in the combined treatment of primary circumscribed malignant melanoma of the skin].
    Korovin SI
    Lik Sprava; 1998 May; (3):114-7. PubMed ID: 9695586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of metastatic melanoma with chemotherapy and biologics.
    Atkins MB
    Curr Opin Oncol; 1997 Mar; 9(2):205-13. PubMed ID: 9161801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of paclitaxel/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma.
    Chang W; Lee SJ; Park S; Choi MK; Hong JY; Kim YS; Maeng CH; Jung HA; Kim S; Lee J
    Melanoma Res; 2013 Apr; 23(2):147-51. PubMed ID: 23411477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.